Randomization and placebo effects in clinical trials of major depressive disorder
Saved in:
Main Authors: | James A. Rogers, Stephen Senn |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-025-03263-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beneficial and harmful effects of duloxetine versus placebo, ‘active placebo’ or no intervention for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
by: Christian Gluud, et al.
Published: (2025-02-01) -
Comparison of Different Machine Learning Methodologies for Predicting the Non‐Specific Treatment Response in Placebo Controlled Major Depressive Disorder Clinical Trials
by: Roberto Gomeni, et al.
Published: (2025-01-01) -
Effectiveness of app-based cognitive behavioral therapy for insomnia on preventing major depressive disorder in youth with insomnia and subclinical depression: A randomized clinical trial.
by: Si-Jing Chen, et al.
Published: (2025-01-01) -
Effectiveness of app-based cognitive behavioral therapy for insomnia on preventing major depressive disorder in youth with insomnia and subclinical depression: A randomized clinical trial
by: Si-Jing Chen, et al.
Published: (2025-01-01) -
Effect of vortioxetine versus venlafaxine on cognitive functions in adults with major depressive disorder: A randomized-controlled trial
by: Chayan K. Manna, et al.
Published: (2023-08-01)